Business
Starpharma pauses UK sales of COVID spray after regulator’s queries – Sydney Morning Herald
The Melbourne biotech has paused sales of its coronavirus fighting product after the UK medicines watchdog wrote to its distributor…
Australian biotech firm Starpharma has paused the sales of its coronavirus-fighting nasal spray in the United Kingdom after the British medicines regulator questioned promotional claims made about the product.
The ASX-listed firm applied the same active…
Continue Reading
-
General22 hours agoMaría Corina Machado awarded Nobel Peace Prize
-
Noosa News22 hours agoQueensland’s bid for net zero by 2050 unlikely under new energy plan: expert
-
General20 hours agoWestern Bulldogs extend Essendon’s losing streak with 57 point thrashing
-
Business11 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies